Literature DB >> 33469008

Epidermal progenitors suppress GRHL3-mediated differentiation through intronic polyadenylation promoted by CPSF-HNRNPA3 collaboration.

Xin Chen1, Sarah M Lloyd1, Junghun Kweon1, Giovanni M Gamalong1, Xiaomin Bao2,3,4.   

Abstract

In self-renewing somatic tissue such as skin epidermis, terminal differentiation genes must be suppressed in progenitors to sustain regenerative capacity. Here we show that hundreds of intronic polyadenylation (IpA) sites are differentially used during keratinocyte differentiation, which is accompanied by downregulation of the Cleavage and Polyadenylation Specificity Factor (CPSF) complex. Sustained CPSF expression in undifferentiated keratinocytes requires the contribution from the transcription factor MYC. In keratinocytes cultured in undifferentiation condition, CSPF knockdown induces premature differentiation and partially affects dynamically used IpA sites. These sites include an IpA site located in the first intron of the differentiation activator GRHL3. CRISPR knockout of GRHL3 IpA increased full-length GRHL3 mRNA expression. Using a targeted genetic screen, we identify that HNRNPA3 interacts with CPSF and enhances GRHL3 IpA. Our data suggest a model where the interaction between CPSF and RNA-binding proteins, such as HNRNPA3, promotes site-specific IpA and suppresses premature differentiation in progenitors.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33469008      PMCID: PMC7815847          DOI: 10.1038/s41467-020-20674-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  62 in total

1.  A developmental switch in transcription factor isoforms during spermatogenesis controlled by alternative messenger RNA 3'-end formation.

Authors:  Hang Wang; Becky L Sartini; Clarke F Millette; Daniel L Kilpatrick
Journal:  Biol Reprod       Date:  2006-05-24       Impact factor: 4.285

2.  Cooperative-binding and splicing-repressive properties of hnRNP A1.

Authors:  Hazeem L Okunola; Adrian R Krainer
Journal:  Mol Cell Biol       Date:  2009-08-10       Impact factor: 4.272

3.  ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis.

Authors:  Sung-Hee Chang; Olivier Elemento; Jiasheng Zhang; Zhen W Zhuang; Michael Simons; Timothy Hla
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

4.  RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing.

Authors:  C G Burd; G Dreyfuss
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

5.  Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.

Authors:  Wangbing Chen; Wei Guo; Mei Li; Dingbo Shi; Yun Tian; Zhenlin Li; Jingshu Wang; Lingyi Fu; Xiangsheng Xiao; Quentin Qiang Liu; Shusen Wang; Wenlin Huang; Wuguo Deng
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

6.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

7.  Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia.

Authors:  Shih-Han Lee; Irtisha Singh; Sarah Tisdale; Omar Abdel-Wahab; Christina S Leslie; Christine Mayr
Journal:  Nature       Date:  2018-08-27       Impact factor: 49.962

8.  DNMT1 maintains progenitor function in self-renewing somatic tissue.

Authors:  George L Sen; Jason A Reuter; Daniel E Webster; Lilly Zhu; Paul A Khavari
Journal:  Nature       Date:  2010-01-17       Impact factor: 49.962

Review 9.  The hnRNP family: insights into their role in health and disease.

Authors:  Thomas Geuens; Delphine Bouhy; Vincent Timmerman
Journal:  Hum Genet       Date:  2016-05-23       Impact factor: 4.132

10.  CALML5 is a ZNF750- and TINCR-induced protein that binds stratifin to regulate epidermal differentiation.

Authors:  Bryan K Sun; Lisa D Boxer; Julia D Ransohoff; Zurab Siprashvili; Kun Qu; Vanessa Lopez-Pajares; S Tyler Hollmig; Paul A Khavari
Journal:  Genes Dev       Date:  2015-11-01       Impact factor: 11.361

View more
  6 in total

1.  Compartment-specific and ELAVL1-coordinated regulation of intronic polyadenylation isoforms by doxorubicin.

Authors:  Alina Chakraborty; Mandy Cadix; Sébastien Relier; Nicolò Taricco; Tina Alaeitabar; Alexandre Devaux; Céline M Labbé; Sylvain Martineau; Amélie Heneman-Masurel; Pierre Gestraud; Alberto Inga; Nicolas Servant; Stéphan Vagner; Martin Dutertre
Journal:  Genome Res       Date:  2022-07-20       Impact factor: 9.438

Review 2.  Context-specific regulation and function of mRNA alternative polyadenylation.

Authors:  Sibylle Mitschka; Christine Mayr
Journal:  Nat Rev Mol Cell Biol       Date:  2022-07-07       Impact factor: 113.915

3.  Transcriptomic and Functional Evidence Show Similarities between Human Amniotic Epithelial Stem Cells and Keratinocytes.

Authors:  Li-Ping Liu; Dong-Xu Zheng; Zheng-Fang Xu; Hu-Cheng Zhou; Yun-Cong Wang; Hang Zhou; Jian-Yun Ge; Daisuke Sako; Mi Li; Kazunori Akimoto; Yu-Mei Li; Yun-Wen Zheng
Journal:  Cells       Date:  2021-12-27       Impact factor: 6.600

Review 4.  Regulation of the Alternative Neural Transcriptome by ELAV/Hu RNA Binding Proteins.

Authors:  Lu Wei; Eric C Lai
Journal:  Front Genet       Date:  2022-02-23       Impact factor: 4.599

5.  CDK9 activity switch associated with AFF1 and HEXIM1 controls differentiation initiation from epidermal progenitors.

Authors:  Sarah M Lloyd; Daniel B Leon; Mari O Brady; Deborah Rodriguez; Madison P McReynolds; Junghun Kweon; Amy E Neely; Laura A Blumensaadt; Patric J Ho; Xiaomin Bao
Journal:  Nat Commun       Date:  2022-07-29       Impact factor: 17.694

Review 6.  Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets.

Authors:  Ya Lu; Xinyue Wang; Quan Gu; Juan Wang; Ying Sui; Jianzhong Wu; Jifeng Feng
Journal:  Cell Death Discov       Date:  2022-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.